GPP

Great Point Partners Portfolio holdings

AUM $154M
This Quarter Return
+5.34%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$633M
AUM Growth
+$633M
Cap. Flow
-$27.5M
Cap. Flow %
-4.35%
Top 10 Hldgs %
62.56%
Holding
43
New
11
Increased
8
Reduced
7
Closed
10
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AMRN
26
Amarin Corp
AMRN
$315M
$3.27M 0.45%
1,056,825
CGEN icon
27
Compugen
CGEN
$133M
$2.51M 0.35%
+759,494
New +$2.51M
CLDX icon
28
Celldex Therapeutics
CLDX
$1.54B
$405K 0.06%
+804,483
New +$405K
STRM
29
DELISTED
Streamline Health Solutions
STRM
$183K 0.03%
130,137
NVLN
30
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$9K ﹤0.01%
+2,500
New +$9K
CPRX icon
31
Catalyst Pharmaceutical
CPRX
$2.43B
-2,695,742
Closed -$6.44M
NBIX icon
32
Neurocrine Biosciences
NBIX
$13.5B
-400,000
Closed -$33.2M
PBYI icon
33
Puma Biotechnology
PBYI
$261M
-500,000
Closed -$34M
PRTA icon
34
Prothena Corp
PRTA
$446M
0
VNDA icon
35
Vanda Pharmaceuticals
VNDA
$278M
-309,800
Closed -$5.22M
VYNE icon
36
VYNE Therapeutics
VYNE
$8.05M
-52,008
Closed -$1.95M
LUMO
37
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
-233,500
Closed -$1.69M
ACOR
38
DELISTED
Acorda Therapeutics, Inc.
ACOR
0
ATRS
39
DELISTED
Antares Pharma, Inc.
ATRS
-500,000
Closed -$1.1M
AIMT
40
DELISTED
Aimmune Therapeutics, Inc.
AIMT
-900,579
Closed -$28.7M
ECYT
41
DELISTED
Endocyte, Inc. Common Stock
ECYT
-1,491,500
Closed -$13.6M
ZGNX
42
DELISTED
Zogenix, Inc.
ZGNX
-978,302
Closed -$39.2M